293 related articles for article (PubMed ID: 22410005)
21. Model for End-Stage Liver Disease (MELD) score and organ allocation from cadaveric donors for 198 liver transplantation procedures performed in a single center.
Santori G; Andorno E; Morelli N; Casaccia M; Bottino G; Ghirelli R; Valente U
Transplant Proc; 2008; 40(6):1903-5. PubMed ID: 18675084
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of model for end-stage liver disease score in patients undergoing liver transplantation with suboptimal livers.
Vitale A; D'Amico F; Brolese A; Zanus G; Boccagni P; Neri D; Gringeri E; Valmasoni M; Ciarleglio FA; Carraro A; Pauletto A; Bonsignore P; Bassi D; Polacco M; D'Amico DF; Cillo U
Transplant Proc; 2007; 39(6):1907-9. PubMed ID: 17692650
[TBL] [Abstract][Full Text] [Related]
23. Long-term outcomes of orthotopic liver transplantation in human immunodeficiency virus-infected patients and comparison with human immunodeficiency virus-negative cases.
Baccarani U; Adani GL; Bragantini F; Londero A; Comuzzi C; Rossetto A; Lorenzin D; Bresadola V; Risaliti A; Pea F; Toniutto P; Donini A; De Anna D; Bresadola F; Tavio M; Viale P
Transplant Proc; 2011 May; 43(4):1119-22. PubMed ID: 21620067
[TBL] [Abstract][Full Text] [Related]
24. D-MELD as a predictor of early graft mortality in adult-to-adult living-donor liver transplantation.
Ikegami T; Imai D; Wang H; Yoshizumi T; Yamashita Y; Ninomiya M; Iguchi T; Bekki Y; Shirabe K; Maehara Y
Transplantation; 2014 Feb; 97(4):457-62. PubMed ID: 24531822
[TBL] [Abstract][Full Text] [Related]
25. Comparable Short- and Long-term Outcomes in Living Donor and Deceased Donor Liver Transplantations for Patients With Model for End-stage Liver Disease Scores ≥35 in a Hepatitis-B Endemic Area.
Chok KS; Fung JY; Chan AC; Dai WC; Sharr WW; Cheung TT; Chan SC; Lo CM
Ann Surg; 2017 Jan; 265(1):173-177. PubMed ID: 28009743
[TBL] [Abstract][Full Text] [Related]
26. [Influence of recipient pretransplant MELD-AS score and graft size on the outcome of adult-to-adult living donor liver transplantation].
Feng X; Wei YG; Li FQ; Yuan D; Jiang H; Du ZG; Yin J; Li B
Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Sep; 39(5):801-4. PubMed ID: 19024318
[TBL] [Abstract][Full Text] [Related]
27. Liver transplantation in septuagenarians receiving model for end-stage liver disease exception points for hepatocellular carcinoma: the national experience.
Schwartz JJ; Pappas L; Thiesset HF; Vargas G; Sorensen JB; Kim RD; Hutson WR; Boucher K; Box T
Liver Transpl; 2012 Apr; 18(4):423-33. PubMed ID: 22250078
[TBL] [Abstract][Full Text] [Related]
28. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
[TBL] [Abstract][Full Text] [Related]
29. The relationship between postoperative intravenous patient-controlled fentanyl analgesic requirements and severity of liver disease.
Ko JS; Shin YH; Gwak MS; Jang CH; Kim GS; Lee SK
Transplant Proc; 2012 Mar; 44(2):445-7. PubMed ID: 22410039
[TBL] [Abstract][Full Text] [Related]
30. The role and limitation of living donor liver transplantation for hepatocellular carcinoma.
Lo CM; Fan ST; Liu CL; Chan SC; Wong J
Liver Transpl; 2004 Mar; 10(3):440-7. PubMed ID: 15004774
[TBL] [Abstract][Full Text] [Related]
31. High MELD score does not adversely affect outcome of living donor liver transplantation: Experience in 1000 recipients.
Yadav SK; Saraf N; Saigal S; Choudhary NS; Goja S; Rastogi A; Bhangui P; Soin AS
Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28497523
[TBL] [Abstract][Full Text] [Related]
32. Assessment of short-term survival after liver transplant by the Model for End-Stage Liver Disease.
Buenadicha AL; Martín LG; Martín EE; Pajares Ad; Pérez AM; Seral CC; Marugán RB
Transplant Proc; 2005 Nov; 37(9):3881-3. PubMed ID: 16386571
[TBL] [Abstract][Full Text] [Related]
33. Analysis of Model for End-Stage Liver Disease (MELD) score in a liver transplantation waiting list.
Ferraz-Neto BH; Hidalgo R; Thomé T; Melo VA; Lobue A; Zurstrassen MP; Moraes JM; Meira-Filho SP; Rezende MB; Fonseca LE; Pandullo FL; Soeiro FS; Afonso RC
Transplant Proc; 2007 Oct; 39(8):2511-3. PubMed ID: 17954160
[TBL] [Abstract][Full Text] [Related]
34. Feasibility of split liver transplantation for 2 adults in the model of end-stage liver disease era.
Lee WC; Chan KM; Chou HS; Wu TJ; Lee CF; Soong RS; Wu TH; Lee CS
Ann Surg; 2013 Aug; 258(2):306-11. PubMed ID: 23108123
[TBL] [Abstract][Full Text] [Related]
35. Short-term postliver transplant survival after the introduction of MELD scores for organ allocation in the United States.
Yoo HY; Thuluvath PJ
Liver Int; 2005 Jun; 25(3):536-41. PubMed ID: 15910490
[TBL] [Abstract][Full Text] [Related]
36. Liver transplantation in recipients over 65 yr old: a single center experience.
Audet M; Piardi T; Panaro F; Cag M; Ghislotti E; Habibeh H; Giulini SM; Jaeck D; Wolf Ph
Clin Transplant; 2010; 24(1):84-90. PubMed ID: 19228173
[TBL] [Abstract][Full Text] [Related]
37. Comparison of MELD and Child-Pugh scores to predict survival after chemoembolization for hepatocellular carcinoma.
Brown DB; Fundakowski CE; Lisker-Melman M; Crippin JS; Pilgram TK; Chapman W; Darcy MD
J Vasc Interv Radiol; 2004 Nov; 15(11):1209-18. PubMed ID: 15525739
[TBL] [Abstract][Full Text] [Related]
38. Use of severely steatotic grafts in liver transplantation: a matched case-control study.
McCormack L; Petrowsky H; Jochum W; Mullhaupt B; Weber M; Clavien PA
Ann Surg; 2007 Dec; 246(6):940-6; discussion 946-8. PubMed ID: 18043095
[TBL] [Abstract][Full Text] [Related]
39. A case-controlled study of the safety and efficacy of transjugular intrahepatic portosystemic shunts after liver transplantation.
King A; Masterton G; Gunson B; Olliff S; Redhead D; Mangat K; Oniscu G; Hayes P; Tripathi D
Liver Transpl; 2011 Jul; 17(7):771-8. PubMed ID: 21714062
[TBL] [Abstract][Full Text] [Related]
40. Younger age and presence of macrovascular invasion were independent significant factors associated with poor disease-free survival in hepatocellular carcinoma patients undergoing living donor liver transplantation.
Wai CT; Woon WA; Tan YM; Lee KH; Tan KC
Transplant Proc; 2012 Mar; 44(2):516-9. PubMed ID: 22410059
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
